- Conditions
- Infertility
- Interventions
- DR-2011, Progesterone 8% Vaginal Gel
- Drug
- Lead sponsor
- Duramed Research
- Industry
- Eligibility
- 18 Years to 50 Years · Female only
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2006
- U.S. locations
- 1
- States / cities
- Norfolk, Virginia
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–11
of 11
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Preterm Delivery, Short Cervix, Short Uterine Cervical Length
- Interventions
- progesterone, placebo
- Drug
- Lead sponsor
- Juniper Pharmaceuticals, Inc.
- Industry
- Eligibility
- 15 Years to 45 Years · Female only
- Enrollment
- 465 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008 – 2010
- U.S. locations
- 27
- States / cities
- Mobile, Alabama • Phoenix, Arizona • Orange, California + 21 more
- Conditions
- Infertility
- Interventions
- Progesterone-IBSA Injectable Solution, Progesterone Vaginal Gel with Applicator, Placebo Vaginal gel with applicator, Placebo injectable solution
- Drug
- Lead sponsor
- IBSA Institut Biochimique SA
- Industry
- Eligibility
- 35 Years to 42 Years · Female only
- Enrollment
- 688 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2026
- U.S. locations
- 24
- States / cities
- Tempe, Arizona • Encino, California • Los Angeles, California + 20 more
- Conditions
- Labor, Premature
- Interventions
- Vaginal progesterone gel, Placebo vaginal gel
- Drug
- Lead sponsor
- University of Rochester
- Other
- Eligibility
- 18 Years and older · Female only
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010
- U.S. locations
- 1
- States / cities
- Rochester, New York
- Conditions
- Polycystic Ovary Syndrome
- Interventions
- Progesterone Vaginal Gel 8%, Letrozole Oral Tablet, pelvic ultrasound, Ovidrel 250 MCG Per 0.5 ML Prefilled Syringe, Intrauterine insemination or timed intercourse
- Drug · Diagnostic Test · Other
- Lead sponsor
- Eastern Virginia Medical School
- Other
- Eligibility
- 20 Years to 40 Years · Female only
- Enrollment
- 52 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2017
- U.S. locations
- 1
- States / cities
- Norfolk, Virginia
- Conditions
- Pregnancy
- Interventions
- 8% progesterone vaginal gel, Placebo Vaginal Gel
- Drug
- Lead sponsor
- Juniper Pharmaceuticals, Inc.
- Industry
- Eligibility
- 18 Years to 45 Years · Female only
- Enrollment
- 636 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2004 – 2009
- U.S. locations
- 45
- States / cities
- Mobile, Alabama • Tucson, Arizona • Colton, California + 39 more
- Conditions
- Infertility
- Interventions
- Vaginal progesterone gel (Crinone® 8%), Intramuscular Progesterone
- Drug
- Lead sponsor
- Brigham and Women's Hospital
- Other
- Eligibility
- 18 Years to 50 Years · Female only
- Healthy volunteers
- Healthy volunteers not accepted
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Infertility
- Interventions
- Crinone 8% Vaginal Gel, Intramuscular Progesterone
- Drug
- Lead sponsor
- Brigham and Women's Hospital
- Other
- Eligibility
- 21 Years to 39 Years · Female only
- Enrollment
- 468 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2009
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Congenital Heart Disease, Periventricular Leucomalacia, Brain Development, Cardiac Surgery, Neurodevelopmental Disability, Fetal Neuroprotection
- Interventions
- Progesterone, Vaginal lubricant
- Drug
- Lead sponsor
- Children's Hospital of Philadelphia
- Other
- Eligibility
- Not listed
- Enrollment
- 102 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2021
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
- Conditions
- Infertility
- Interventions
- DR-2011, Crinone 8%
- Drug
- Lead sponsor
- Duramed Research
- Industry
- Eligibility
- 18 Years to 42 Years · Female only
- Enrollment
- 1,297 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008 – 2009
- U.S. locations
- 29
- States / cities
- Tarzana, California • West Los Angeles, California • Westlake, California + 26 more
- Conditions
- Infertility, Pregnancy
- Interventions
- Crinone vaginal progesterone gel, Placebo vaginal gel
- Drug
- Lead sponsor
- Wake Forest University Health Sciences
- Other
- Eligibility
- 18 Years to 40 Years · Female only
- Enrollment
- 20 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008 – 2010
- U.S. locations
- 1
- States / cities
- Charlotte, North Carolina